Executives
CEOHeun Soo KangPh.D
- CEO, Cell2in Inc.
- Former Senior Medical Researcher at Seoul National University
- Former researcher at NIH/NHLBI, USA
- Former manager of Pharmaceutical Team and R&D Center of Daesang Corp.
- Ph.D. in Pharmaceutical Chemistry, University of Vienna, Austria
CTOIn-Gyu KimPh.D
- CTO, Cell2in Inc.
- Professor Emeritus at Department of Biochemistry and Molecular Biology at Seoul National University College of Medicine
- Former researcher at NIH/NHLBI, USA
- M.D. & Ph.D. in biochemistry, Seoul National University College of Medicine
CFOGwang-Rak Park
- Vice President, Cell2in Inc.: Supervision of Open Innovation
- CEO, CURACLE Co., Ltd. - Supervision of new drug biotech venture management and conduction of IPO operation
- Venture incubating and management consulting
- CFO and general management executive in the manufacturing industry
- B.A. in business administration, Seoul National University
Vice PresidentDae-Kwon JooPh.D
- Vice President, Cell2in Inc.: Supervision of Open Innovation
- Former manager of Bio Business Team and R&D Center of Daesang Corp.
- Bioengineering at KAIST
- Ph.D. In Bioengineering, University of Technology of Compiègne, France
Technical advisory group
Dong-Myung Shin
Cell therapy research and development
- Professor of Biomedical Sciences, University of Ulsan College of Medicine
- Ph.D., Seoul National University College of Medicine
Kihang Choi
Cell quality measurement substance synthesis and development
- Professor of Organic Chemistry, Korea University
- Ph.D., Yale University, USA
Ssang-Goo Cho
Customized cell culture medium development
- Professor of Department of Stem Cell and Regenerative Biotechnology, Konkuk University
- Ph.D., Korea University
Eui Man Jeong
Stem cell therapy mechanism research
- Professor of Department of Pharmacy, Jeju National University
- Ph.D., Seoul National University College of Medicine